Medical therapies for ulcerative colitis: a practical update Ulcerative colitis is an increasingly prevalent inflammatory condition of the bowel that results in abdominal pain, diarrhoea, rectal bleeding and urgency
There is emerging evidence that GLP-1 receptor agonists may help reduce autoimmune inflammation, including in conditions like rheumatoid arthritis and lupus, although more studies are needed
Smoking, hypertension, high cholesterol, diabetes, physical inactivity, obesity, and an unhealthy dietary pattern remain among the most important modifiable heart-disease risk factors
Units refers to a standard U-100 insulin syringe , where 100 units equals 1.0 mL
Dose-dependent pancreatitis risk associated with GLP-1 agonists